Skip to main content
TipRanks
Go Ultimate75% OFF

James M Karis Insider Profile

4 Followers

James M Karis, Director at Shield Therapeutics, holds 161.67K shares in Shield Therapeutics (Ticker: GB:STX). Most recently, James M Karis Bought 75,000 shares of Shield Therapeutics on Aug 15, 2019 for an estimated value of 133.50K .

James M Karis's Trading History

STX
Shield Therapeutics
Aug 15, 2019DirectorInformative Buy133.50K£4.85K
GB:STX
Insider Shares: 161.67K (13.80%)
DateTransactionAmountNo. of SharesPrice per ShareProfitLink to Report
Aug 15, 2019Informative Buy£133.50K75,000£178.00-29.80%―
Apr 17, 2019Informative Buy$53.50K50,000$1.07+15.40%―
Jun 15, 2017Informative Buy£55.00K36,667£150.00-73.90%―

You May Also Like

James M Karis insider profile FAQ

What is the percentage of profitable transactions made by James M Karis?
The percentage of profitable transactions made by James M Karis is 33%.
What is the average return per transaction made by James M Karis?
The average return per transaction made by James M Karis is -29.40%.
What stocks does James M Karis hold?
James M Karis holds: GB:STX stocks.
What was James M Karis’s latest transaction?
James M Karis’s latest transaction was an Informative Buy of 133.50K .
What was James M Karis's most profitable transaction?
James M Karis’s most profitable transaction was an Informative Buy of GB:STX stock on April 17, 2019. The return on the trade was 15.40%.
What is James M Karis's role in Shield Therapeutics?
James M Karis's role in Shield Therapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.